MHRA hires top global tech talent to transform systems behind regulation of medicines and medical devices
The Medicines and Healthcare products Regulatory Agency (MHRA) is pleased to announce the appointment of Jason Bonander as its new Chief Digital and Technology Officer (CDTO). Joining in late May 2026, the appointment of Jason strengthens the Agency’s leadership expertise in health data and technologies as it gets ready to deliver a new 5-year strategy […]
Regulation reset to fast-track homes, transport and clean energy
Communities will get new homes, better transport and cleaner energy sooner, thanks to a more dynamic, modern approach to regulation. New guidelines in the form of Strategic Policy Statements will give Natural England and the Environment Agency – the two most powerful environmental regulators – a mandate to prioritise outcomes over process, speeding up decision-making while maintaining high environmental standards. This will be backed by £100 million, spread over three years, to fund specialist staff and modern […]
Regulation as an Enabler of Innovation: A Regional Perspective
MHRA Foreword At the MHRA, our role is to give patients and the public confidence in the safety, effectiveness and quality of emerging health technologies. Innovation and regulation work best together—enabling new solutions to be adopted quickly while upholding the highest standards of protection and trust. As outlined by Richard Stubbs in the next of […]
Patients to benefit sooner as UK boosts clinical trials attractiveness with faster assessments and agile regulation
The UK is ramping up efforts to become a global first choice for clinical trials, as new figures published today (13 January), show a sharp rise in activity in 2025, and changes coming this year – including a fast-track route – that will help companies get studies up and running more quickly, so patients can benefit from new treatments sooner. Data from the Medicines and […]